Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified family nurse practitioner (FNP) is preparing to begin
independent prescribing in a state that grants full practice authority.
Which action best demonstrates appropriate professional responsibility
before initiating pharmacotherapy?
A. Prescribing medications based primarily on previous nursing
experience
B. Developing a process to review evidence-based guidelines, state
regulations, and individual patient factors before prescribing
C. Limiting prescribing to medications frequently used by collaborating
physicians
D. Relying primarily on pharmaceutical representatives for prescribing
updates
Correct Answer: B
Rationale:
Advanced practice prescribers are responsible for integrating current
evidence, legal requirements, patient-specific factors, and clinical
judgment into prescribing decisions. Developing a systematic approach
to evidence-based prescribing promotes patient safety and professional
accountability. Previous nursing experience alone is insufficient for
prescribing decisions. Restricting prescribing to medications used by
others does not ensure evidence-based care. Pharmaceutical
representatives may provide information but should not serve as the
primary source of prescribing knowledge.
,Question 2
An AGPCNP evaluates a 78-year-old patient with hypertension,
osteoarthritis, type 2 diabetes, and chronic kidney disease who takes
nine medications. Which prescribing principle is most appropriate?
A. Add medications for every uncontrolled symptom
B. Prioritize medications with the longest duration of action
C. Evaluate for polypharmacy and deprescribing opportunities before
adding new medications
D. Avoid changing medications that were prescribed by another
clinician
Correct Answer: C
Rationale:
Polypharmacy increases the risk of adverse drug events, drug
interactions, falls, and nonadherence, particularly in older adults.
APRNs should assess medication necessity, effectiveness, safety, and
adherence before initiating additional therapy. Adding medications
without evaluation may worsen polypharmacy. Duration of action alone
should not guide therapy. APRNs should appropriately evaluate and
modify therapies when clinically indicated.
Question 3
A PMHNP prescribes a medication for generalized anxiety disorder.
Before initiating therapy, the patient asks about risks and benefits.
Which ethical principle most directly supports providing this
information?
A. Fidelity
, B. Justice
C. Beneficence
D. Autonomy
Correct Answer: D
Rationale:
Patient autonomy requires that individuals receive sufficient
information to make informed healthcare decisions. Discussing risks,
benefits, alternatives, and expected outcomes supports informed
consent. Fidelity involves maintaining trust and commitments.
Beneficence involves promoting patient welfare. Justice focuses on
fairness and equitable treatment.
Question 4
A WHNP is considering treatment options for a pregnant patient with a
newly diagnosed infection. Which factor should receive the highest
priority when selecting pharmacotherapy?
A. Medication cost alone
B. Prescriber familiarity with the drug
C. Maternal and fetal safety data
D. Frequency of dosing
Correct Answer: C
Rationale:
In pregnancy, maternal and fetal safety are primary considerations.
APRNs must evaluate available evidence regarding teratogenicity, fetal
effects, maternal benefit, and available alternatives. Cost, convenience,
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A newly certified family nurse practitioner (FNP) is preparing to begin
independent prescribing in a state that grants full practice authority.
Which action best demonstrates appropriate professional responsibility
before initiating pharmacotherapy?
A. Prescribing medications based primarily on previous nursing
experience
B. Developing a process to review evidence-based guidelines, state
regulations, and individual patient factors before prescribing
C. Limiting prescribing to medications frequently used by collaborating
physicians
D. Relying primarily on pharmaceutical representatives for prescribing
updates
Correct Answer: B
Rationale:
Advanced practice prescribers are responsible for integrating current
evidence, legal requirements, patient-specific factors, and clinical
judgment into prescribing decisions. Developing a systematic approach
to evidence-based prescribing promotes patient safety and professional
accountability. Previous nursing experience alone is insufficient for
prescribing decisions. Restricting prescribing to medications used by
others does not ensure evidence-based care. Pharmaceutical
representatives may provide information but should not serve as the
primary source of prescribing knowledge.
,Question 2
An AGPCNP evaluates a 78-year-old patient with hypertension,
osteoarthritis, type 2 diabetes, and chronic kidney disease who takes
nine medications. Which prescribing principle is most appropriate?
A. Add medications for every uncontrolled symptom
B. Prioritize medications with the longest duration of action
C. Evaluate for polypharmacy and deprescribing opportunities before
adding new medications
D. Avoid changing medications that were prescribed by another
clinician
Correct Answer: C
Rationale:
Polypharmacy increases the risk of adverse drug events, drug
interactions, falls, and nonadherence, particularly in older adults.
APRNs should assess medication necessity, effectiveness, safety, and
adherence before initiating additional therapy. Adding medications
without evaluation may worsen polypharmacy. Duration of action alone
should not guide therapy. APRNs should appropriately evaluate and
modify therapies when clinically indicated.
Question 3
A PMHNP prescribes a medication for generalized anxiety disorder.
Before initiating therapy, the patient asks about risks and benefits.
Which ethical principle most directly supports providing this
information?
A. Fidelity
, B. Justice
C. Beneficence
D. Autonomy
Correct Answer: D
Rationale:
Patient autonomy requires that individuals receive sufficient
information to make informed healthcare decisions. Discussing risks,
benefits, alternatives, and expected outcomes supports informed
consent. Fidelity involves maintaining trust and commitments.
Beneficence involves promoting patient welfare. Justice focuses on
fairness and equitable treatment.
Question 4
A WHNP is considering treatment options for a pregnant patient with a
newly diagnosed infection. Which factor should receive the highest
priority when selecting pharmacotherapy?
A. Medication cost alone
B. Prescriber familiarity with the drug
C. Maternal and fetal safety data
D. Frequency of dosing
Correct Answer: C
Rationale:
In pregnancy, maternal and fetal safety are primary considerations.
APRNs must evaluate available evidence regarding teratogenicity, fetal
effects, maternal benefit, and available alternatives. Cost, convenience,
